Kanatani Masanori, Sugimoto Toshitsugu, Sowa Hideaki, Kobayashi Tatsuya, Kanzawa Michiko, Chihara Kazuo
Division of Endocrinology/Metabolism, Neurology, and Hematology/Oncology, Department of Clinical Molecular Medicine, Kobe University Graduate School of Medicine, Kobe, Japan.
J Cell Physiol. 2004 Oct;201(1):17-25. doi: 10.1002/jcp.20041.
It is well known that thyroid hormone excess causes bone loss. However, the precise mechanism of bone loss by thyroid hormone still remains unclear. When T(3) was added to unfractionated bone cells after degeneration of pre-existent osteoclasts, T(3) (1 pM-100 nM) dose-dependently stimulated osteoclast-like cell formation, irrespective of the presence of indomethacin and IL-6 Ab. T(3) increased the expression of osteoprotegerin (OPG) messenger RNA (mRNA), but not of receptor activator of nuclear factor kappaB ligand (RANKL) in unfractionated bone cells, suggesting that the stimulatory effect of T(3) on osteoclast formation was not mediated by the RANKL/OPG system. We next examined the direct effect of T(3) on osteoclast precursors in the absence of osteoblasts, using hemopoietic blast cells derived from spleen cells. T(3) (1 pM-100 nM) dose-dependently stimulated osteoclast-like cell formation from osteoclast precursors. OPG did not inhibit T(3)-induced osteoclast formation from osteoclast precursor cells. The polymerase chain reaction (PCR) product corresponding in size to the mouse T(3) receptor alpha1 cDNA was detected in osteoclast precursors from mouse hemopoietic blast cells as well as mouse heart and mouse osteoblastic cell line MC3T3-E1 cells, suggesting that T(3) directly stimulated osteoclast-like cell formation from osteoclast precursors in the absence of osteoblasts. Further, T(3) increased the expression of c-Fos mRNA at 15 min and 24 h and Fra-1 mRNA at 2 and 6 h in osteoclast precursors. Consistent with the increased expression of c-Fos mRNA observed by RT-PCR, the activation of c-Fos occurred in osteoclast precursor cells stimulated by T(3), while the activation of neither NF-kappaB nor MAPKs was observed by immunoblot analysis. Antisense oligodeoxynucleotides (as-ODN) complementary to c-Fos mRNA at 1 microM significantly inhibited T(3)-induced osteoclast-like cell formation from osteoclast precursors in the absence of stromal cells while sense-ODN did not affect T(3)-induced osteoclast-like cell formation. These results indicate that T(3) directly stimulates osteoclast differentiation at least in part by up-regulation of c-fos protein in osteoclast precursor cells.
众所周知,甲状腺激素过多会导致骨质流失。然而,甲状腺激素导致骨质流失的确切机制仍不清楚。当在已存在的破骨细胞退化后将T(3)添加到未分离的骨细胞中时,T(3)(1 pM - 100 nM)剂量依赖性地刺激破骨细胞样细胞形成,与吲哚美辛和IL-6抗体的存在无关。T(3)增加了未分离骨细胞中骨保护素(OPG)信使核糖核酸(mRNA)的表达,但未增加核因子κB受体激活剂配体(RANKL)的表达,这表明T(3)对破骨细胞形成的刺激作用不是由RANKL/OPG系统介导的。接下来,我们使用源自脾细胞的造血母细胞,在无成骨细胞的情况下研究了T(3)对破骨细胞前体的直接作用。T(3)(1 pM - 100 nM)剂量依赖性地刺激破骨细胞前体形成破骨细胞样细胞。OPG并未抑制T(3)诱导的破骨细胞前体细胞形成破骨细胞。在来自小鼠造血母细胞以及小鼠心脏和小鼠成骨细胞系MC3T3-E1细胞的破骨细胞前体中,检测到了大小与小鼠T(3)受体α1 cDNA相对应的聚合酶链反应(PCR)产物,这表明T(3)在无成骨细胞的情况下直接刺激破骨细胞前体形成破骨细胞样细胞。此外,T(3)在破骨细胞前体中于15分钟和24小时增加了c-Fos mRNA的表达,并在2小时和6小时增加了Fra-1 mRNA的表达。与通过逆转录聚合酶链反应(RT-PCR)观察到的c-Fos mRNA表达增加一致,c-Fos在T(3)刺激的破骨细胞前体细胞中被激活,而通过免疫印迹分析未观察到核因子κB(NF-κB)或丝裂原活化蛋白激酶(MAPKs)的激活。与c-Fos mRNA互补的1 microM反义寡脱氧核苷酸(as-ODN)在无基质细胞的情况下显著抑制了T(3)诱导的破骨细胞前体形成破骨细胞样细胞,而正义寡脱氧核苷酸(sense-ODN)不影响T(3)诱导的破骨细胞样细胞形成。这些结果表明,T(3)至少部分地通过上调破骨细胞前体细胞中的c-fos蛋白直接刺激破骨细胞分化。